kr82.50: That's What Analysts Think Havila Kystruten AS (OB:HKY) Is Worth After Its Latest Results

The analyst might have been a bit too bullish on Havila Kystruten AS (OB:HKY), given that the company fell short of expectations when it released its quarterly results last week. It was a pretty negative result overall, with revenues of kr416m missing analyst predictions by 8.1%. Worse, the business reported a statutory loss of kr15.90 per share, much larger than the analyst had forecast prior to the result. Following the result, the analyst has updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. We've gathered the most recent statutory forecasts to see whether the analyst has changed their earnings models, following these results.

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Following last week's earnings report, Havila Kystruten's sole analyst are forecasting 2025 revenues to be kr1.83b, approximately in line with the last 12 months. Per-share losses are predicted to creep up to kr63.64. Before this earnings announcement, the analyst had been modelling revenues of kr1.83b and losses of kr65.24 per share in 2025. So there seems to have been a moderate uplift in analyst sentiment with the latest consensus release, given the upgrade to loss per share forecasts for this year.

Check out our latest analysis for Havila Kystruten

The consensus price target fell 5.7% to kr82.50despite the forecast for smaller losses next year. It looks like the ongoing lack of profitability is starting to weigh on valuations.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Havila Kystruten's past performance and to peers in the same industry. It's pretty clear that there is an expectation that Havila Kystruten's revenue growth will slow down substantially, with revenues to the end of 2025 expected to display 1.5% growth on an annualised basis. This is compared to a historical growth rate of 58% over the past five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 6.6% annually. So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than Havila Kystruten.

The Bottom Line

The most obvious conclusion is that the analyst made no changes to their forecasts for a loss next year. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target fell measurably, with the analyst seemingly not reassured by the latest results, leading to a lower estimate of Havila Kystruten's future valuation.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have analyst estimates for Havila Kystruten going out as far as 2027, and you can see them free on our platform here.

We don't want to rain on the parade too much, but we did also find 3 warning signs for Havila Kystruten (1 is significant!) that you need to be mindful of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.